WRF Capital

WRF Capital is the investment arm of the Washington Research Foundation, dedicated to accelerating the commercialization of innovative technologies developed within Washington state's nonprofit research institutions. Since its inception in 1996, WRF Capital has invested in 132 local startups, primarily focusing on spinouts from institutions such as the University of Washington, Washington State University, Fred Hutchinson Cancer Research Center, and the Institute for Systems Biology. The firm aims to transform groundbreaking ideas into successful businesses that benefit the public.

The firm's investment strategy emphasizes early-stage funding, typically ranging from $100,000 to $5 million, to support the development of technologies with life sciences applications. WRF Capital's portfolio spans various sectors, including biotechnology, pharmaceuticals, medical devices, digital health, enterprise software, internet-based solutions, advanced materials, and scientific instrumentation. By partnering with entrepreneurs, research institutions, and other investors, WRF Capital plays a pivotal role in bringing innovative products and services to market.

With a strong commitment to fostering innovation, WRF Capital leverages its deep connections within Washington's research community to identify and support promising startups. The firm's comprehensive approach includes thorough due diligence, active involvement in portfolio companies, and a focus on creating value through strategic guidance and resources. This dedication has contributed to the growth and success of numerous companies, reinforcing WRF Capital's reputation as a key player in the region's entrepreneurial ecosystem.